Posts tagged GlaxoSmithKline
A redundant scientist is earning ‘top’ money in the plumbing industry after taking a training course with top trades’ school ATL, the Daily Mirror has revealed.
Leading trade skills provider ATL made news across the country today after laboratory scientist Steve Banks hung up his test tubes and went looking for a way to turn his life round.
And Steve, aged 43, who has two sons, Mathew and Daniel, as well as a three-year old girl Ruby and lives with his wife, Naomi, said he wished he had taken the plunge years ago.
Steve told the Daily Mirror: “I started looking around for courses I could do in my own time while carrying on working and asking people for recommendations and found that ATL had a very good reputation.”
When Steve was made redundant in 2009, he had almost completed his plumbing course and was about to set up his own business… Now he earns about £45,000 a year, much more than in his previous job.
Steve said: “It was great really, I got so much confidence from the course that my business grew through word of mouth.”
Altogether, Steve from Letchworth, Herts, spent about £6,500 from his redundancy money on his training. “This was a lifetime investment for me and it is paying off.”
Steve says that he is a very practical person who always enjoys doing things with his hands. He used to help his father who was working in the building trades before he retired.
Like every new thing, Steve admits that his business was slow to start with, but soon people began to ring him, saying that a friend had recommended his services. Now he is thinking of employing extra people to help him.
The pharmaceutical giant GlaxoSmithKline (GSK) has confirmed an investment of £500 million across its manufacturing sites to increase production of its products whilst providing a major boost for the UK’s construction and manufacturing industry.
The company announced today it will build a new state-of-the-art manufacturing facility in Cumbria, North of England. An investment of £350 million for building the new facility would create hundreds of jobs and provide work opportunities for people in the building sector.
Building construction work is anticipated to begin within the next two years depending on obtaining the necessary planning consents. It is likely to take up to 6 years before the new facility is entirely completed.
The significant investment comes after Chancellor of the Exchequer, George Osborne, confirmed yesterday in Budget 2012, the government’s commitment to introduce a lower rate of corporation tax on profits generated from UK-owned intellectual property.
Chief Executive at GSK, Sir Andrew Witty, said: “The introduction of the patent box has transformed the way in which we view the UK as a location for new investments, ensuring that the medicines of the future will not only be discovered, but can also continue to be made here in Britain.”
Prime Minister David Cameron welcomed the investment as “excellent news” for businesses saying that cutting business tax will attract further investment to the British economy.
“It shows why we are right to cut business tax and focus on making the UK a dynamic and competitive place that can attract exactly this type of high tech investment.”- Mr Cameron said.
Additional investment of more than £100 million was also confirmed for GSK’s two manufacturing sites in Irvine and Montrose, Scotland. The company also said that it will invest in sustainable green energy production and environmentally friendly manufacturing technologies in the future.